Aquestive Therapeutics to Present Anaphylm Progress at Piper Sandler Healthcare Conference
I'm PortAI, I can summarize articles.
Aquestive Therapeutics Inc. will present the regulatory progress and commercial readiness of Anaphylm™ at the Piper Sandler Healthcare Conference in New York City from December 2-4, 2025. A fireside chat is scheduled for December 4, 2025, at 10:00 a.m. ET, with a webcast available on their website. Investor meetings will also be held on the same day.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments